Invention Grant
- Patent Title: Strain of Enterobacter for degrading hyaluronic acid and application thereof
-
Application No.: US17818240Application Date: 2022-08-08
-
Publication No.: US11807847B2Publication Date: 2023-11-07
- Inventor: Jinsong Shi , Zhenghong Xu , Jinsong Gong , Wei Liu , Hui Li , Jianying Qian , Lei Liu , Qing Li , Mengyi Zhang , Chuanli Kang
- Applicant: JIANGNAN UNIVERSITY , Shandong Focusfreda Biotech Co., Ltd
- Applicant Address: CN Jiangsu
- Assignee: JIANGNAN UNIVERSITY
- Current Assignee: JIANGNAN UNIVERSITY
- Current Assignee Address: CN Jiangsu
- Agency: Magstone Law, LLP
- Agent Enshan Hong
- Priority: CN 1911365498.0 2019.12.26
- The original application number of the division: US17134296 2020.12.26
- Main IPC: C12N1/20
- IPC: C12N1/20 ; C12R1/01

Abstract:
The invention belongs to the field of cosmetic biotechnology, and specifically relates to an Enterobacter that degrades hyaluronic acid and a cultivation method and application thereof. The Enterobacter sp. CGJ001 of the present invention was deposited in the China General Microbiological Culture Collection Center on Oct. 10, 2019, and the preservation number is CGMCC NO. 18661. The Enterobacter strain can efficiently produce hyaluronidase, and can be used in the process of preparing low molecular hyaluronic acid and oligomeric hyaluronic acid from high molecular hyaluronic acid. The enzyme has high specificity towards hyaluronic acid, excellent thermal stability and pH stability, and is suitable for large-scale industrial application. Thus, it can replace the traditional hyaluronidase extracted from expensive animal tissues. There should be broad application prospects in the fields of medicine and cosmetics.
Public/Granted literature
- US20230024365A1 STRAIN OF ENTEROBACTER FOR DEGRADING HYALURONIC ACID AND APPLICATION THEREOF Public/Granted day:2023-01-26
Information query
IPC分类: